Preprint Case Report Version 1 Preserved in Portico This version is not peer-reviewed

Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol

Version 1 : Received: 23 December 2020 / Approved: 23 December 2020 / Online: 23 December 2020 (16:12:26 CET)

How to cite: Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints 2020, 2020120597 (doi: 10.20944/preprints202012.0597.v1). Duarte, F.; De Oliveira, L. Peri-Implantitis - Decontaminating and Regenerative Treatment Protocol. Preprints 2020, 2020120597 (doi: 10.20944/preprints202012.0597.v1).

Abstract

Peri-implant diseases are defined as pathological inflammatory reactions in the tissue surrounding the osseointegrated implants. They are classified into two categories: mucositis - defined as peri-implant soft tissue inflammation and peri-implantitis - bone loss in the peri-implant region. A clinical case of a 61-years-old woman with an implant in the 46 anatomical position and a 5-year follow-up is presented. A probe depth of 5mm and a bone defect length of 35% was observed. The Implacure® Protocol was applied, with the main objective of eliminating the biofilm present on the exposed implant surface. There are multiple approaches to treat peri-implant diseases. While non-surgical treatment is essential for mucositis control, the treatment of peri-implantitis surgical treatment should be considered. Regenerative bone reconstruction promotes bone repair in the defect area and reduces bleeding during probing. To achieve that, autologous fibrin combined with Cerasorb M® was used. The proposed approach in the exposed clinical case involves the application of Implacure® Protocol, whose combination of the physical decontamination technique, together with the use of chlorhexidine and orthophosphoric acid, added with the combination Piperacillin + Tazobactam together with hyaluronic acid, provide a base that allows to regenerate bone using platelet-rich fibrin with Cerasorb M® and increase the survival time of the implant.

Subject Areas

Peri-implantitis; Implacure® Protocol; Platelet-rich Fibrin

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.